HF-CARB (Chronic Ambulatory HF Risk Model) Calculator

Clinical calculation support · Verify results before clinical use

Clinical assessment

Each present risk item contributes one point. Total score: 0-5.

--Score / 5
NYHA functional class III-IV

NYHA functional class III-IV

Is the patient in NYHA class III or IV?

+1 point
Clinical signs of congestion

Clinical signs of congestion

Are clinical signs of congestion present?

+1 point
Recent HF decompensation

Recent HF decompensation

HF admission or emergency department visit for decompensation in the previous 12 months.

+1 point
Loop diuretic dose

Loop diuretic dose

Daily furosemide dose >= 40 mg, or an equivalent loop-diuretic dose.

+1 point
NT-proBNP

NT-proBNP

NT-proBNP >= 1,000 pg/mL. If unavailable, selecting No may undercount risk.

+1 point

About the HF-CARB / IC-BERG clinical model

This five-item clinical model was evaluated in an observational historical cohort of 1,909 ambulatory patients with heart failure. Investigators counted five clinical features and examined their association with adverse outcomes.

Items and scoring

Clinical itemCriterionPoints
NYHA classClass III-IV1
CongestionClinical signs present1
Recent decompensationHF admission for decompensation in previous 12 months1
Loop diureticDaily furosemide >= 40 mg or equivalent1
NT-proBNP>= 1,000 pg/mL1

Published adjusted hazard ratios

Number of itemsAdjusted HR95% CI
01.00Reference group
11.471.00-2.15
22.031.41-2.92
32.982.08-4.28
45.073.51-7.32
57.735.21-11.45

Hazard ratios for 1-5 items were reported relative to the group with zero items for the combined endpoint of death or HF admission. They describe relative hazards in the study cohort and should not be interpreted as risk ratios or absolute probabilities.

References

Barge-Caballero E, Barge-Caballero G, Paniagua-Martín MJ, et al.Prognostic value of a model based on IC-BERG recommendations in ambulatory patients with heart failure. REC: CardioClinics. 2022;57(2):76-84. doi:10.1016/j.rccl.2021.06.004
Heidenreich PA, Bozkurt B, Aguilar D, et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145:e895-e1032. doi:10.1161/CIR.0000000000001063
Clinical disclaimer: This calculator is an educational aid for clinical risk assessment, not a substitute for clinical judgement or a fully validated individual risk prediction model. The published model was evaluated in a specific observational cohort; external validation and transportability to other populations have not been confirmed here. Do not use the score alone to determine treatment, follow-up intervals, referral, or advanced heart failure care.